Zegalogue .6 mg/.6mL

Zegalogue .6 mg/.6mL is a glucagon injection used for severe hypoglycemia. This solution is designed for subcutaneous administration and is manufactured by Novo Nordisk in the USA.

Zegalogue .6 mg/.6mL is primarily used to treat severe hypoglycemia, a condition characterized by very low blood sugar levels. It works by raising blood sugar levels quickly. This medication is often used in emergency situations where oral glucose is not effective or practical. People with diabetes who are at risk of severe hypoglycemia may carry this injection for urgent use.

Common effects of Zegalogue .6 mg/.6mL may include nausea, vomiting, and injection site reactions. Some users might experience dizziness or headache. These effects are generally mild and temporary. Severe side effects are rare but should be reported to a healthcare provider immediately.

Zegalogue .6 mg/.6mL should be handled with care. It is important to store it properly and use it as directed. People with certain medical conditions, such as insulinomas, should consult a healthcare provider before use. Always follow the instructions provided with the medication to ensure safe and effective use.

Zegalogue .6 mg/.6mL may interact with other medications, including beta-blockers and indomethacin. Alcohol consumption should be avoided as it can affect blood sugar levels. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.